Clinical Trial Update: How Reducing Anxiety in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating anxiety reduction in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Institut de Recherche Biomedicale des Armees | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED